Zinc finger protein 217 (ZNF217) was proven as miR-503 target, it is demonstrated that GATA3/miR-503 axis suppressed the progression of prostate cancer by inhibiting ZNF217 expression. The gene discussed is ZNF217; the disease is prostate cancer.